Pictet Asset Management (UK)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Pictet Asset Management (UK)’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$28M	Sell	157,657 -73,920	-32%	-$12.8M	0.03%	453
2021 Q1	$38.1M	Sell	231,577 -48,571	-17%	-$7.99M	0.05%	387
2020 Q4	$46.2M	Buy	280,148 +16,395	+6%	+$2.44M	0.06%	319
2020 Q3	$37.6M	Sell	263,753 -13,600	-5%	-$1.69M	0.06%	315
2020 Q2	$30.6M	Sell	277,353 -18,515	-6%	-$2.05M	0.05%	323
2020 Q1	$29.5M	Sell	295,868 -4,700	-2%	-$608K	0.06%	296
2019 Q4	$44.9M	Buy	+300,568	New	+$40.9M	0.08%	286

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management (UK)'s JAZZ Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Jazz Pharmaceuticals (JAZZ) stake by 32% in Q2 2021, selling an estimated $12.8M and leaving 157,657 shares worth $28M. The position accounts for 0.03% of the portfolio, ranked #453.

Pictet Asset Management (UK) first reported a position in JAZZ in Q4 2019 and has held it in 7 quarters since. The position peaked at $46.2M in Q4 2020. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

Pictet Asset Management (UK) held 157,657 shares of Jazz Pharmaceuticals worth $28M as of Q2 2021.
Pictet Asset Management (UK) sold 73,920 Jazz Pharmaceuticals shares in Q2 2021, an estimated $12.8M.
Jazz Pharmaceuticals made up 0.03% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #453 holding.
Pictet Asset Management (UK) first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 7 quarters since.
Pictet Asset Management (UK)'s Jazz Pharmaceuticals position peaked at $46.2M in Q4 2020.
505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.